Kyverna Therapeutics News

Kyverna Therapeutics | 8-K: Current report

Jun 14 06:14 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Karen Marie

Jun 10 18:59 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jones Ryan Alexander

May 29 16:42 ET

Kyverna Therapeutics | 10-Q: Quarterly report

May 14 16:35 ET

Kyverna Therapeutics | 8-K: Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

May 14 16:31 ET

Kyverna Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Vida Ventures, LLC(11.1%),VV Manager LLC(11.1%), etc.

May 3 18:03 ET

Kyverna Therapeutics | 10-K: Annual report

Mar 26 16:45 ET

Kyverna Therapeutics | 8-K: Current report

Mar 26 16:18 ET

Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(7.6%),Northpond Ventures III, LP(6.5%), etc.

Feb 22 16:34 ET

Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(9 . 6%)

Feb 20 16:39 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Vida Ventures, LLC

Feb 14 19:08 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E

Feb 14 19:08 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SEIDENBERG BETH C

Feb 14 18:58 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Westlake BioPartners Fund I, L.P.

Feb 14 17:41 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Bain Capital Life Sciences Investors, LLC

Feb 14 17:28 ET

Kyverna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bain Capital Life Sciences Opportunities III, LP(7.4%)

Feb 14 17:23 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.

Feb 13 17:52 ET

Kyverna Therapeutics | SEC STAFF LETTER: Others

Feb 13 11:01 ET

Kyverna Therapeutics | 4: Statement of changes in beneficial ownership of securities- Northpond Ventures III GP, LLC

Feb 12 17:55 ET

Kyverna Therapeutics | 8-K: Current report

Feb 12 16:39 ET